Women’s health providers’ perspectives on preimplantation genetic testing
Preimplantation Genetic Testing (PGT) is a commonly used procedure to screen for genetic abnormalities in an embryo prior to transfer. Patients with medical indications for PGT may be identified and counseled by OB/GYN providers, gynecologic oncologists, or infertility specialists. The attitudes of women’s health providers among these specialties regarding PGT has not been well characterized.
Source: fertstert.org
Women’s health providers’ perspectives on preimplantation genetic testing
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection
Be First to Comment